CONMED
CNMD
230 hedge funds and large institutions have $2.5B invested in CONMED in 2019 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 78 increasing their positions, 77 reducing their positions, and 32 closing their positions.
264% more call options, than puts
Call options by funds: $1.75M | Put options by funds: $479K
22% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 32
2% more funds holding
Funds holding: 226 → 230 (+4)
3% more capital invested
Capital invested by funds: $2.42B → $2.5B (+$82M)
1% more repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 77
0.22% more ownership
Funds ownership: 103.38% → 103.6% (+0.22%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$30.3M |
| 2 |
Nuveen
Charlotte,
North Carolina
|
+$24M |
| 3 |
Principal Financial Group
Des Moines,
Iowa
|
+$12.5M |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$12M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$11.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$19.7M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$16.4M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$14.4M |
| 4 |
Goldman Sachs
New York
|
-$12.9M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$9.72M |
CNMD Hedge Fund Activity: Q2 2019 in Review
230 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q2 2019, worth a combined $2.5B — up 3.4% from $2.42B a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new CNMD positions and 32 closed out — a net gain of 7 holders — while 78 added to existing stakes and 77 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $30.3M. The largest seller was Marshall Wace, cutting an estimated $19.7M.
- 230 institutional investors held CONMED (CNMD) as of Q2 2019, up from 226 in Q1 2019.
- Funds reported $2.5B of CONMED stock for Q2 2019, up 3.4% quarter-over-quarter.
- 39 funds opened new CONMED positions in Q2 2019 and 32 closed out, a net change of +7 holders.
- The largest CONMED buyer in Q2 2019 was Capital Research Global Investors, an estimated $30.3M added.
- The largest CONMED seller in Q2 2019 was Marshall Wace, an estimated $19.7M sold.
Based on aggregated 13F filings for Q2 2019.